{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:13:07Z","timestamp":1656799987676},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-022-04469-6","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T21:32:16Z","timestamp":1656797536000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fusidic acid in a tertiary hospital: an observational study focusing on prescriptions, tolerance and susceptibility of Staphylococcus and Cutibacterium spp. strains from bone samples"],"prefix":"10.1007","author":[{"given":"Juliette","family":"Romaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Limelette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique Vernet","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohan","family":"N\u2019Guyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"issue":"8","key":"4469_CR1","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.arth.2017.03.005","volume":"32","author":"L Drago","year":"2017","unstructured":"Drago L, De Vecchi E, Bortolin M, Zagra L, Roman\u00f2 CL, Cappelletti L (2017) Epidemiology and antibiotic resistance of late prosthetic knee and hip infections. J Arthroplasty 32(8):2496\u20132500","journal-title":"J Arthroplasty"},{"issue":"1","key":"4469_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13073-017-0504-3","volume":"9","author":"AE Paharik","year":"2017","unstructured":"Paharik AE, Schreiber HL 4th, Spaulding CN, Dodson KW, Hultgren SJ (2017) Narrowing the spectrum: the new frontier of precision antimicrobials. Genome Med 9(1):110","journal-title":"Genome Med"},{"issue":"3","key":"4469_CR3","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.01823-12","volume":"57","author":"L Armand-Lef\u00e8vre","year":"2013","unstructured":"Armand-Lef\u00e8vre L, Angebault C, Barbier F, Hamelet E, Defrance G, Rupp\u00e9 E et al (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57(3):1488\u201395","journal-title":"Antimicrob Agents Chemother"},{"key":"4469_CR4","unstructured":"(2009) Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF); Coll\u00e8ge des Universitaires de Maladies Infectieuses et Tropicales (CMIT); Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP); Soci\u00e9t\u00e9 Fran\u00e7aise d'Anesth\u00e9sie et de R\u00e9animation (SFAR); Soci\u00e9t\u00e9 Fran\u00e7aise de Chirurgie Orthop\u00e9dique et Traumatologique (SOFCOT); Soci\u00e9t\u00e9 Fran\u00e7aise d'Hygi\u00e8ne Hospitali\u00e8re (SFHH) et al. Clinical practice recommendations. Osteoarticular infections on materials (prosthesis, implant, osteosynthesis. Med Mal Infect 39(11):815\u201363."},{"issue":"1","key":"4469_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56(1):e1\u2013e25","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4469_CR6","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1093\/jac\/dkz202","volume":"74","author":"M Benkabouche","year":"2019","unstructured":"Benkabouche M, Racloz G, Spechbach H, Lipsky BA, Gaspoz JM, U\u00e7kay I (2019) Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial. J Antimicrob Chemother 74(8):2394\u20132399","journal-title":"J Antimicrob Chemother"},{"issue":"19","key":"4469_CR7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","volume":"279","author":"W Zimmerli","year":"1998","unstructured":"Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279(19):1537\u201341","journal-title":"JAMA"},{"issue":"2","key":"4469_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jinf.2015.03.013","volume":"71","author":"A Bernard","year":"2015","unstructured":"Bernard A, Kermarrec G, Parize P, Caruba T, Bouvet A, Mainardi JL et al (2015) Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination. J Infect 71(2):200\u2013206","journal-title":"J Infect"},{"key":"4469_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1472-8206.2007.00490.x","volume":"21","author":"F Roblot","year":"2007","unstructured":"Roblot F, Besnier JM, Giraudeau B, Simonnard N, Jonville-Bera AP, Coipeau P et al (2007) Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections. Fundam Clin Pharmacol 21:363\u2013369","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"4469_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/cid\/ciab145","volume":"73","author":"NJ Vollmer","year":"2021","unstructured":"Vollmer NJ, Rivera CG, Stevens RW, Oravec CP, Mara KC, Suh GA et al (2021) Safety and tolerability of fluoroquinolones in patients with staphylococcal periprosthetic Joint Infections. Clin Infect Dis 73(5):850\u2013856","journal-title":"Clin Infect Dis"},{"key":"4469_CR11","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1111\/bjd.15500","volume":"177","author":"P Mendes-Bastos","year":"2017","unstructured":"Mendes-Bastos P, Macedo R, Duarte R (2017) Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis? Br J Dermatol 177:e150\u2013e151","journal-title":"Br J Dermatol"},{"issue":"Suppl 7","key":"4469_CR12","doi-asserted-by":"publisher","first-page":"S477","DOI":"10.1093\/cid\/cir163","volume":"52","author":"RN Jones","year":"2011","unstructured":"Jones RN, Mendes RE, Sader HS, Castanheira M (2011) In vitro antimicrobial findings for fusidic acid tested against contemporary (2008\u20132009) gram-positive organisms collected in the United States. Clin Infect Dis 52(Suppl 7):S477\u2013S486","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4469_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/10408347.2015.1084225","volume":"46","author":"MM Curbete","year":"2016","unstructured":"Curbete MM, Salgado HR (2016) A critical review of the properties of fusidic acid and analytical methods for its determination. Crit Rev Anal Chem 46(4):352\u2013360","journal-title":"Crit Rev Anal Chem"},{"issue":"Suppl 1","key":"4469_CR14","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/jac\/dku253","volume":"69","author":"AM Minassian","year":"2014","unstructured":"Minassian AM, Osmon DR, Berendt AR (2014) Clinical guidelines in the management of prosthetic joint infection. J Antimicrob Chemother 69(Suppl 1):i29-35","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"4469_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijantimicag.2015.12.002","volume":"47","author":"S Klein","year":"2016","unstructured":"Klein S, Nurjadi D, Eigenbrod T, Bode KA (2016) Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid? Int J Antimicrob Agents 47(2):155\u2013157","journal-title":"Int J Antimicrob Agents"},{"key":"4469_CR16","unstructured":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. European Committee on Antimicrobial Susceptibility Testing. Guidelines 2021 (April). https:\/\/www.sfm-microbiologie.org\/wp-content\/uploads\/2021\/04\/CASFM2021__V1.0.AVRIL_2021.pdf. (accessed July 27th)"},{"issue":"2","key":"4469_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/014107680209500211","volume":"95","author":"M Biswas","year":"2002","unstructured":"Biswas M, Owen K, Jones MK (2002) Hypocalcaemia during fusidic acid therapy. J R Soc Med 95(2):91\u201393","journal-title":"J R Soc Med"},{"issue":"3","key":"4469_CR18","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1097\/MJT.0000000000000679","volume":"26","author":"M Bataillard","year":"2019","unstructured":"Bataillard M, Beyens MN, Mounier G, Vergnon-Miszczycha D, Bagheri H, Cathebras P (2019) Muscle damage due to fusidic acid-statin interaction: review of 75 cases from the French pharmacovigilance database and literature reports. Am J Ther 26(3):e375\u2013e379","journal-title":"Am J Ther"},{"issue":"Suppl 7","key":"4469_CR19","doi-asserted-by":"publisher","first-page":"S487","DOI":"10.1093\/cid\/cir164","volume":"52","author":"DJ Farrell","year":"2011","unstructured":"Farrell DJ, Castanheira M, Chopra I (2011) Characterization of global patterns and the genetics of fusidic acid resistance. Clin Infect Dis 52(Suppl 7):S487-92","journal-title":"Clin Infect Dis"},{"issue":"12","key":"4469_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/cid\/ciw665","volume":"63","author":"R Pushkin","year":"2016","unstructured":"Pushkin R, Iglesias-Ussel MD, Keedy K, MacLauchlin C, Mould DR, Berkowitz R et al (2016) A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of-care antibiotics for treatment of prosthetic joint infections: a newly identified drug-drug interaction. Clin Infect Dis 63(12):1599\u20131604","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4469_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/147323000203000509","volume":"30","author":"M Ertek","year":"2002","unstructured":"Ertek M, Yazgi H, Erol S, Altoparlak U (2002) Demonstration of in vitro antagonism between fusidic acid and quinolones. J Int Med Res 30(5):525\u2013528","journal-title":"J Int Med Res"},{"issue":"7","key":"4469_CR22","doi-asserted-by":"publisher","first-page":"e00598","DOI":"10.1128\/AAC.00598-18","volume":"62","author":"W Siala","year":"2018","unstructured":"Siala W, Rodriguez-Villalobos H, Fernandes P, Tulkens PM, Van Bambeke F (2018) Activities of combinations of antistaphylococcal antibiotics with fusidic acid against staphylococcal biofilms in in vitro static and dynamic models. Antimicrob Agents Chemother 62(7):e00598-e618","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4469_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13756-021-00943-6","volume":"10","author":"B Hajikhani","year":"2021","unstructured":"Hajikhani B, Goudarzi M, Kakavandi S, Amini S, Zamani S, van Belkum A et al (2021) The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis. Antimicrob Resist Infect Control 10(1):75","journal-title":"Antimicrob Resist Infect Control"},{"key":"4469_CR24","doi-asserted-by":"publisher","first-page":"4582756","DOI":"10.1155\/2017\/4582756","volume":"2017","author":"B Fink","year":"2017","unstructured":"Fink B, Sevelda F (2017) Periprosthetic joint infection of shoulder arthroplasties: diagnostic and treatment options. Biomed Res Int 2017:4582756","journal-title":"Biomed Res Int"},{"issue":"1S","key":"4469_CR25","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.otsr.2017.05.030","volume":"104","author":"P Boisrenoult","year":"2018","unstructured":"Boisrenoult P (2018) Cutibacterium acnes prosthetic joint infection: diagnosis and treatment. Orthop Traumatol Surg Res 104(1S):S19\u2013S24","journal-title":"Orthop Traumatol Surg Res"},{"issue":"6","key":"4469_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5194\/jbji-6-219-2021","volume":"6","author":"U Hedlundh","year":"2021","unstructured":"Hedlundh U, Zacharatos M, Magnusson J, Gottlander M, Karlsson J (2021) Periprosthetic hip infections in a Swedish regional hospital between 2012 and 2018: is there a relationship between Cutibacterium acnes infections and uncemented prostheses? J Bone Jt Infect 6(6):219\u2013228","journal-title":"J Bone Jt Infect"},{"issue":"Suppl B","key":"4469_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/25.suppl_B.7","volume":"25","author":"M Faber","year":"1990","unstructured":"Faber M, Rosdahl VT (1990) Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption. J Antimicrob Chemother 25(Suppl B):7\u201314","journal-title":"J Antimicrob Chemother"},{"issue":"21","key":"4469_CR28","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa2020198","volume":"384","author":"L Bernard","year":"2021","unstructured":"Bernard L, Arvieux C, Brunschweiler B, Touchais S, Ansart S, Bru JP et al (2021) Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med 384(21):1991\u20132001","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04469-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T21:32:26Z","timestamp":1656797546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04469-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":28,"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04469-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data confidentiality was preserved throughout this internal study (Reims University Hospital GDPR register number RMR004-03072021), in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The patients were not required to provide individual consent because of the retrospective and non-interventional nature of this study, in accordance with French legislation. No patient had previously objected to the further use of their medical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written consent was obtained from the two patients, whose cases had been reported as InternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}